Finanças

Discussões Sinais técnicos Previsão Sazonais

Lucro líquido antes das operações descontinuadas de IBNSINA PHARMA.

Dados anuais

2016

2017

2018

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪100,00 M‬‬

‪‪200,00 M‬‬

‪‪300,00 M‬‬

‪‪400,00 M‬‬

Período

Valor

Variação

Variação %

TTM

‪‪361,37 M‬‬

+‪‪188,23 M‬‬

+‪108,72‬%

2023

‪‪173,14 M‬‬

+‪‪40,93 M‬‬

+‪30,96‬%

2022

‪‪132,21 M‬‬

‪‪−154,12 M‬‬

‪−53,83‬%

2021

‪‪286,33 M‬‬

+‪‪102,22 M‬‬

+‪55,52‬%

2020

‪‪184,11 M‬‬

‪‪−119,06 M‬‬

‪−39,27‬%

2019

‪‪303,17 M‬‬

+‪‪60,87 M‬‬

+‪25,12‬%

2018

2017

2016

Dados trimestrais

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪40,00 M‬‬

‪‪80,00 M‬‬

‪‪120,00 M‬‬

‪‪160,00 M‬‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪149,78 M‬‬

+‪‪49,79 M‬‬

+‪49,79‬%

Q2 '24

‪‪100,00 M‬‬

+‪‪20,50 M‬‬

+‪25,79‬%

Q1 '24

‪‪79,50 M‬‬

+‪‪47,40 M‬‬

+‪147,69‬%

Q4 '23

‪‪32,09 M‬‬

‪‪−1,95 M‬‬

‪−5,73‬%

Q3 '23

‪‪34,05 M‬‬

‪‪−14,67 M‬‬

‪−30,11‬%

Q2 '23

‪‪48,72 M‬‬

‪‪−8,59 M‬‬

‪−14,99‬%

Q1 '23

‪‪57,31 M‬‬

+‪‪22,13 M‬‬

+‪62,92‬%

Q4 '22

‪‪35,18 M‬‬

+‪‪10,05 M‬‬

+‪39,98‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19

Q4 '18

Q3 '18

Q2 '18

Q1 '18

Q4 '17

Q3 '17

Q2 '17